IDH3A and central nervous system cancer: Moreover, a recent study comparing relative genome-wide RNA-editing levels among genetic subgroups of glioma showed that the RNA-editing signature can be used for the prediction of isocitrate dehydrogenase (IDH) mutation and chromosome 1p/19q-codeletion status in gliomas48.